Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale

The cerebellar cognitive affective syndrome scale (CCAS-S) was designed to detect specific cognitive dysfunctions in cerebellar patients but is scarcely validated in spinocerebellar ataxias (SCA). The objective of this study is to determine the usefulness of the CCAS-S in a Cuban cohort of SCA2 pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cerebellum (London, England) England), 2022-06, Vol.21 (3), p.391-403
Hauptverfasser: Rodríguez-Labrada, Roberto, Batista-Izquierdo, Alejandro, González-Melix, Zuleyra, Reynado-Cejas, Lorenzo, Vázquez-Mojena, Yaimeé, Sanz, Yuri Arsenio, Canales-Ochoa, Nalia, González-Zaldívar, Yanetza, Dogan, Imis, Reetz, Kathrin, Velázquez-Pérez, Luis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 403
container_issue 3
container_start_page 391
container_title Cerebellum (London, England)
container_volume 21
creator Rodríguez-Labrada, Roberto
Batista-Izquierdo, Alejandro
González-Melix, Zuleyra
Reynado-Cejas, Lorenzo
Vázquez-Mojena, Yaimeé
Sanz, Yuri Arsenio
Canales-Ochoa, Nalia
González-Zaldívar, Yanetza
Dogan, Imis
Reetz, Kathrin
Velázquez-Pérez, Luis
description The cerebellar cognitive affective syndrome scale (CCAS-S) was designed to detect specific cognitive dysfunctions in cerebellar patients but is scarcely validated in spinocerebellar ataxias (SCA). The objective of this study is to determine the usefulness of the CCAS-S in a Cuban cohort of SCA2 patients and the relationship of its scores with disease severity. The original scale underwent a forward and backward translation into Spanish language, followed by a pilot study to evaluate its comprehensibility. Reliability, discriminant, and convergent validity assessments were conducted in 64 SCA2 patients and 64 healthy controls matched for sex, age, and education. Fifty patients completed the Montreal Cognitive Assessment (MoCA) test. The CCAS-S showed an acceptable internal consistency (Cronbach’s alpha = 0.74) while its total raw score and the number of failed tests showed excellent (ICC = 0.94) and good (ICC = 0.89) test–retest reliability, respectively. Based on original cut-offs, the sensitivity of CCAS-S to detect possible/probable/definite CCAS was notably high (100%/100%/91%), but specificities were low (6%/30/64%) because the decreased specificity observed in four items. CCAS-S performance was significantly influenced by ataxia severity in patients and by education in both groups. CCAS-S scores correlated with MoCA scores, but showed higher sensitivity than MoCA to detect cognitive impairments in patients. The CCAS-S is particularly useful to detect cognitive impairments in SCA2 but some transcultural and/or age and education-dependent adaptations could be necessary to improve its diagnostic properties. Furthermore, this scale confirmed the parallelism between cognitive and motor deficits in SCA2, giving better insights into the disease pathophysiology and identifying novel outcomes for clinical trials.
doi_str_mv 10.1007/s12311-021-01305-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2555637632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2663837492</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-1ea6fa98a23b7abb6d20121e9d9be0fcf84d4d2958ae594b788c02d87df3c6be3</originalsourceid><addsrcrecordid>eNp9kU1PHCEYx0ljU632C3hoSLz0Mi1v8-Zts62tiUkPq70SBp5xMTOwAqMdP4afuGxXa9NDEwjk4ff8gfwQOqbkIyWk_hQp45QWhOVJOSmLh1fogIqaF4JxsvfXfh-9jfGGEMaIqN-gfS445S1vDtDj0l87m-wd4M-gB-sAn0e8HHyEYcaLGL22KoHB9zat8SKpn1bhFdxBsGnG1uHVxjqvIUAHw6DCM3I5bwCzU6zwDzVYo5L1mU2TmbHvcVoDXun1qPJwuT47E_y4rakBjtDrXg0R3j2th-jq7Mvl8ltx8f3r-XJxUWjB2lRQUFWv2kYx3tWq6yrDCGUUWtN2QHrdN8IIw9qyUVC2oqubRhNmmtr0XFcd8EP0YZe7Cf52gpjkaKPe_sKBn6JkZVlWvK44y-jJP-iNn4LLr5OsqnjDa9FuKbajdPAxBujlJthRhVlSIrfG5M6YzMbkb2PyITe9f4qeuhHMn5ZnRRngOyDmI3cN4eXu_8T-AjZcowQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2663837492</pqid></control><display><type>article</type><title>Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Rodríguez-Labrada, Roberto ; Batista-Izquierdo, Alejandro ; González-Melix, Zuleyra ; Reynado-Cejas, Lorenzo ; Vázquez-Mojena, Yaimeé ; Sanz, Yuri Arsenio ; Canales-Ochoa, Nalia ; González-Zaldívar, Yanetza ; Dogan, Imis ; Reetz, Kathrin ; Velázquez-Pérez, Luis</creator><creatorcontrib>Rodríguez-Labrada, Roberto ; Batista-Izquierdo, Alejandro ; González-Melix, Zuleyra ; Reynado-Cejas, Lorenzo ; Vázquez-Mojena, Yaimeé ; Sanz, Yuri Arsenio ; Canales-Ochoa, Nalia ; González-Zaldívar, Yanetza ; Dogan, Imis ; Reetz, Kathrin ; Velázquez-Pérez, Luis</creatorcontrib><description>The cerebellar cognitive affective syndrome scale (CCAS-S) was designed to detect specific cognitive dysfunctions in cerebellar patients but is scarcely validated in spinocerebellar ataxias (SCA). The objective of this study is to determine the usefulness of the CCAS-S in a Cuban cohort of SCA2 patients and the relationship of its scores with disease severity. The original scale underwent a forward and backward translation into Spanish language, followed by a pilot study to evaluate its comprehensibility. Reliability, discriminant, and convergent validity assessments were conducted in 64 SCA2 patients and 64 healthy controls matched for sex, age, and education. Fifty patients completed the Montreal Cognitive Assessment (MoCA) test. The CCAS-S showed an acceptable internal consistency (Cronbach’s alpha = 0.74) while its total raw score and the number of failed tests showed excellent (ICC = 0.94) and good (ICC = 0.89) test–retest reliability, respectively. Based on original cut-offs, the sensitivity of CCAS-S to detect possible/probable/definite CCAS was notably high (100%/100%/91%), but specificities were low (6%/30/64%) because the decreased specificity observed in four items. CCAS-S performance was significantly influenced by ataxia severity in patients and by education in both groups. CCAS-S scores correlated with MoCA scores, but showed higher sensitivity than MoCA to detect cognitive impairments in patients. The CCAS-S is particularly useful to detect cognitive impairments in SCA2 but some transcultural and/or age and education-dependent adaptations could be necessary to improve its diagnostic properties. Furthermore, this scale confirmed the parallelism between cognitive and motor deficits in SCA2, giving better insights into the disease pathophysiology and identifying novel outcomes for clinical trials.</description><identifier>ISSN: 1473-4230</identifier><identifier>ISSN: 1473-4222</identifier><identifier>EISSN: 1473-4230</identifier><identifier>DOI: 10.1007/s12311-021-01305-z</identifier><identifier>PMID: 34313938</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adaptation ; Ataxia ; Biomedical and Life Sciences ; Biomedicine ; Cerebellar Ataxia ; Cerebellar Diseases ; Cerebellum ; Clinical trials ; Cognitive ability ; Cognitive Dysfunction - diagnosis ; Humans ; Neurobiology ; Neurology ; Neurosciences ; Original Article ; Patients ; Pilot Projects ; Reproducibility of Results ; Spinocerebellar ataxia ; Spinocerebellar Ataxias - complications ; Spinocerebellar Ataxias - diagnosis ; Syndrome ; Validation studies</subject><ispartof>Cerebellum (London, England), 2022-06, Vol.21 (3), p.391-403</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-1ea6fa98a23b7abb6d20121e9d9be0fcf84d4d2958ae594b788c02d87df3c6be3</citedby><cites>FETCH-LOGICAL-c429t-1ea6fa98a23b7abb6d20121e9d9be0fcf84d4d2958ae594b788c02d87df3c6be3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12311-021-01305-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12311-021-01305-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34313938$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodríguez-Labrada, Roberto</creatorcontrib><creatorcontrib>Batista-Izquierdo, Alejandro</creatorcontrib><creatorcontrib>González-Melix, Zuleyra</creatorcontrib><creatorcontrib>Reynado-Cejas, Lorenzo</creatorcontrib><creatorcontrib>Vázquez-Mojena, Yaimeé</creatorcontrib><creatorcontrib>Sanz, Yuri Arsenio</creatorcontrib><creatorcontrib>Canales-Ochoa, Nalia</creatorcontrib><creatorcontrib>González-Zaldívar, Yanetza</creatorcontrib><creatorcontrib>Dogan, Imis</creatorcontrib><creatorcontrib>Reetz, Kathrin</creatorcontrib><creatorcontrib>Velázquez-Pérez, Luis</creatorcontrib><title>Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale</title><title>Cerebellum (London, England)</title><addtitle>Cerebellum</addtitle><addtitle>Cerebellum</addtitle><description>The cerebellar cognitive affective syndrome scale (CCAS-S) was designed to detect specific cognitive dysfunctions in cerebellar patients but is scarcely validated in spinocerebellar ataxias (SCA). The objective of this study is to determine the usefulness of the CCAS-S in a Cuban cohort of SCA2 patients and the relationship of its scores with disease severity. The original scale underwent a forward and backward translation into Spanish language, followed by a pilot study to evaluate its comprehensibility. Reliability, discriminant, and convergent validity assessments were conducted in 64 SCA2 patients and 64 healthy controls matched for sex, age, and education. Fifty patients completed the Montreal Cognitive Assessment (MoCA) test. The CCAS-S showed an acceptable internal consistency (Cronbach’s alpha = 0.74) while its total raw score and the number of failed tests showed excellent (ICC = 0.94) and good (ICC = 0.89) test–retest reliability, respectively. Based on original cut-offs, the sensitivity of CCAS-S to detect possible/probable/definite CCAS was notably high (100%/100%/91%), but specificities were low (6%/30/64%) because the decreased specificity observed in four items. CCAS-S performance was significantly influenced by ataxia severity in patients and by education in both groups. CCAS-S scores correlated with MoCA scores, but showed higher sensitivity than MoCA to detect cognitive impairments in patients. The CCAS-S is particularly useful to detect cognitive impairments in SCA2 but some transcultural and/or age and education-dependent adaptations could be necessary to improve its diagnostic properties. Furthermore, this scale confirmed the parallelism between cognitive and motor deficits in SCA2, giving better insights into the disease pathophysiology and identifying novel outcomes for clinical trials.</description><subject>Adaptation</subject><subject>Ataxia</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cerebellar Ataxia</subject><subject>Cerebellar Diseases</subject><subject>Cerebellum</subject><subject>Clinical trials</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Humans</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Original Article</subject><subject>Patients</subject><subject>Pilot Projects</subject><subject>Reproducibility of Results</subject><subject>Spinocerebellar ataxia</subject><subject>Spinocerebellar Ataxias - complications</subject><subject>Spinocerebellar Ataxias - diagnosis</subject><subject>Syndrome</subject><subject>Validation studies</subject><issn>1473-4230</issn><issn>1473-4222</issn><issn>1473-4230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1PHCEYx0ljU632C3hoSLz0Mi1v8-Zts62tiUkPq70SBp5xMTOwAqMdP4afuGxXa9NDEwjk4ff8gfwQOqbkIyWk_hQp45QWhOVJOSmLh1fogIqaF4JxsvfXfh-9jfGGEMaIqN-gfS445S1vDtDj0l87m-wd4M-gB-sAn0e8HHyEYcaLGL22KoHB9zat8SKpn1bhFdxBsGnG1uHVxjqvIUAHw6DCM3I5bwCzU6zwDzVYo5L1mU2TmbHvcVoDXun1qPJwuT47E_y4rakBjtDrXg0R3j2th-jq7Mvl8ltx8f3r-XJxUWjB2lRQUFWv2kYx3tWq6yrDCGUUWtN2QHrdN8IIw9qyUVC2oqubRhNmmtr0XFcd8EP0YZe7Cf52gpjkaKPe_sKBn6JkZVlWvK44y-jJP-iNn4LLr5OsqnjDa9FuKbajdPAxBujlJthRhVlSIrfG5M6YzMbkb2PyITe9f4qeuhHMn5ZnRRngOyDmI3cN4eXu_8T-AjZcowQ</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Rodríguez-Labrada, Roberto</creator><creator>Batista-Izquierdo, Alejandro</creator><creator>González-Melix, Zuleyra</creator><creator>Reynado-Cejas, Lorenzo</creator><creator>Vázquez-Mojena, Yaimeé</creator><creator>Sanz, Yuri Arsenio</creator><creator>Canales-Ochoa, Nalia</creator><creator>González-Zaldívar, Yanetza</creator><creator>Dogan, Imis</creator><creator>Reetz, Kathrin</creator><creator>Velázquez-Pérez, Luis</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20220601</creationdate><title>Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale</title><author>Rodríguez-Labrada, Roberto ; Batista-Izquierdo, Alejandro ; González-Melix, Zuleyra ; Reynado-Cejas, Lorenzo ; Vázquez-Mojena, Yaimeé ; Sanz, Yuri Arsenio ; Canales-Ochoa, Nalia ; González-Zaldívar, Yanetza ; Dogan, Imis ; Reetz, Kathrin ; Velázquez-Pérez, Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-1ea6fa98a23b7abb6d20121e9d9be0fcf84d4d2958ae594b788c02d87df3c6be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adaptation</topic><topic>Ataxia</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cerebellar Ataxia</topic><topic>Cerebellar Diseases</topic><topic>Cerebellum</topic><topic>Clinical trials</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Humans</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Original Article</topic><topic>Patients</topic><topic>Pilot Projects</topic><topic>Reproducibility of Results</topic><topic>Spinocerebellar ataxia</topic><topic>Spinocerebellar Ataxias - complications</topic><topic>Spinocerebellar Ataxias - diagnosis</topic><topic>Syndrome</topic><topic>Validation studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodríguez-Labrada, Roberto</creatorcontrib><creatorcontrib>Batista-Izquierdo, Alejandro</creatorcontrib><creatorcontrib>González-Melix, Zuleyra</creatorcontrib><creatorcontrib>Reynado-Cejas, Lorenzo</creatorcontrib><creatorcontrib>Vázquez-Mojena, Yaimeé</creatorcontrib><creatorcontrib>Sanz, Yuri Arsenio</creatorcontrib><creatorcontrib>Canales-Ochoa, Nalia</creatorcontrib><creatorcontrib>González-Zaldívar, Yanetza</creatorcontrib><creatorcontrib>Dogan, Imis</creatorcontrib><creatorcontrib>Reetz, Kathrin</creatorcontrib><creatorcontrib>Velázquez-Pérez, Luis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cerebellum (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodríguez-Labrada, Roberto</au><au>Batista-Izquierdo, Alejandro</au><au>González-Melix, Zuleyra</au><au>Reynado-Cejas, Lorenzo</au><au>Vázquez-Mojena, Yaimeé</au><au>Sanz, Yuri Arsenio</au><au>Canales-Ochoa, Nalia</au><au>González-Zaldívar, Yanetza</au><au>Dogan, Imis</au><au>Reetz, Kathrin</au><au>Velázquez-Pérez, Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale</atitle><jtitle>Cerebellum (London, England)</jtitle><stitle>Cerebellum</stitle><addtitle>Cerebellum</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>21</volume><issue>3</issue><spage>391</spage><epage>403</epage><pages>391-403</pages><issn>1473-4230</issn><issn>1473-4222</issn><eissn>1473-4230</eissn><abstract>The cerebellar cognitive affective syndrome scale (CCAS-S) was designed to detect specific cognitive dysfunctions in cerebellar patients but is scarcely validated in spinocerebellar ataxias (SCA). The objective of this study is to determine the usefulness of the CCAS-S in a Cuban cohort of SCA2 patients and the relationship of its scores with disease severity. The original scale underwent a forward and backward translation into Spanish language, followed by a pilot study to evaluate its comprehensibility. Reliability, discriminant, and convergent validity assessments were conducted in 64 SCA2 patients and 64 healthy controls matched for sex, age, and education. Fifty patients completed the Montreal Cognitive Assessment (MoCA) test. The CCAS-S showed an acceptable internal consistency (Cronbach’s alpha = 0.74) while its total raw score and the number of failed tests showed excellent (ICC = 0.94) and good (ICC = 0.89) test–retest reliability, respectively. Based on original cut-offs, the sensitivity of CCAS-S to detect possible/probable/definite CCAS was notably high (100%/100%/91%), but specificities were low (6%/30/64%) because the decreased specificity observed in four items. CCAS-S performance was significantly influenced by ataxia severity in patients and by education in both groups. CCAS-S scores correlated with MoCA scores, but showed higher sensitivity than MoCA to detect cognitive impairments in patients. The CCAS-S is particularly useful to detect cognitive impairments in SCA2 but some transcultural and/or age and education-dependent adaptations could be necessary to improve its diagnostic properties. Furthermore, this scale confirmed the parallelism between cognitive and motor deficits in SCA2, giving better insights into the disease pathophysiology and identifying novel outcomes for clinical trials.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>34313938</pmid><doi>10.1007/s12311-021-01305-z</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-4230
ispartof Cerebellum (London, England), 2022-06, Vol.21 (3), p.391-403
issn 1473-4230
1473-4222
1473-4230
language eng
recordid cdi_proquest_miscellaneous_2555637632
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adaptation
Ataxia
Biomedical and Life Sciences
Biomedicine
Cerebellar Ataxia
Cerebellar Diseases
Cerebellum
Clinical trials
Cognitive ability
Cognitive Dysfunction - diagnosis
Humans
Neurobiology
Neurology
Neurosciences
Original Article
Patients
Pilot Projects
Reproducibility of Results
Spinocerebellar ataxia
Spinocerebellar Ataxias - complications
Spinocerebellar Ataxias - diagnosis
Syndrome
Validation studies
title Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A44%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Decline%20Is%20Closely%20Associated%20with%20Ataxia%20Severity%20in%20Spinocerebellar%20Ataxia%20Type%202:%20a%20Validation%20Study%20of%20the%20Schmahmann%20Syndrome%20Scale&rft.jtitle=Cerebellum%20(London,%20England)&rft.au=Rodr%C3%ADguez-Labrada,%20Roberto&rft.date=2022-06-01&rft.volume=21&rft.issue=3&rft.spage=391&rft.epage=403&rft.pages=391-403&rft.issn=1473-4230&rft.eissn=1473-4230&rft_id=info:doi/10.1007/s12311-021-01305-z&rft_dat=%3Cproquest_cross%3E2663837492%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2663837492&rft_id=info:pmid/34313938&rfr_iscdi=true